Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo …

…, A Vishnevsky, AW Cavalcante, K Zirpe - The lancet Respiratory …, 2021 - thelancet.com
Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory
properties. This study evaluates the efficacy and safety of baricitinib in combination …

Determination of brain death/death by neurologic criteria: the world brain death project

…, Y Su, SD Timmons, J Teitelbaum, W Videtta, K Zirpe… - Jama, 2020 - jamanetwork.com
Importance There are inconsistencies in concept, criteria, practice, and documentation of
brain death/death by neurologic criteria (BD/DNC) both internationally and within countries. …

[HTML][HTML] Intensive care in India: The Indian intensive care case mix and practice patterns study

…, S Dhanuka, V Singh, R Tewari, K Zirpe… - Indian journal of …, 2016 - ncbi.nlm.nih.gov
Aims: To obtain information on organizational aspects, case mix and practices in Indian
Intensive Care Units (ICUs). Patients and Methods: An observational, 4-day point prevalence …

[HTML][HTML] ISCCM guidelines for the use of non-invasive ventilation in acute respiratory failure in adult ICUs

R Chawla, SB Dixit, KG Zirpe, D Chaudhry… - Indian journal of …, 2020 - ncbi.nlm.nih.gov
A. ACUTE HYPERCAPNIC RESPIRATORY FAILURE A1. Acute Exacerbation of COPD:
Recommendations: NIV should be used in management of acute exacerbation of COPD in …

[HTML][HTML] Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

…, JF Timsit, JA Roberts, JR Zahar, F Zand, K Zirpe… - Intensive Care …, 2020 - Springer
Purpose The DIANA study aimed to evaluate how often antimicrobial de-escalation (ADE) of
empirical treatment is performed in the intensive care unit (ICU) and to estimate the effect of …

[HTML][HTML] Methicillin-resistant Staphylococcus aureus in intensive care unit setting of India: a review of clinical burden, patterns of prevalence, preventive measures, and …

Y Mehta, A Hegde, R Pande, KG Zirpe… - Indian journal of …, 2020 - ncbi.nlm.nih.gov
Aim The aim of this review article is not only to analyze the clinical burden of methicillin-resistant
Staphylococcus aureus (MRSA) in intensive care unit (ICU) setting of India, along with …

[HTML][HTML] The second-vs First-wave COVID-19: more of the same or a lot worse? A comparison of mortality between the two waves in patients admitted to intensive care …

KG Zirpe, S Dixit, AP Kulkarni, RA Pandit… - Indian journal of …, 2021 - ncbi.nlm.nih.gov
Background India, along with the rest of the world, faced the challenging severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. The second wave in India lagged …

[PDF][PDF] A retrospective analysis of risk factors of Covid-19 associated mucormycosis and mortality predictors: a single-center study

K Zirpe, P Pote, A Deshmukh, SK Gurav, AM Tiwari… - Cureus, 2021 - cureus.com
Background Mucormycosis has been identified with increasing frequency in patients with
coronavirus disease 2019 (COVID-19). Aims We aimed to determine the in-hospital outcome of …

[HTML][HTML] Timing of invasive mechanical ventilation and mortality among patients with severe COVID-19-associated acute respiratory distress syndrome

KG Zirpe, AM Tiwari, SK Gurav… - Indian journal of …, 2021 - ncbi.nlm.nih.gov
Background Severe acute respiratory distress syndrome associated with coronavirus
disease-2019 (COVID-19)(CARDS) pneumonitis presents a clinical challenge as regards to the …

[HTML][HTML] Guidelines for antibiotic prescription in intensive care unit

GC Khilnani, K Zirpe, V Hadda, Y Mehta… - Indian journal of …, 2019 - ncbi.nlm.nih.gov
How to cite this article: Khilnani GC, Zirpe K, Hadda V, Mehta Y, Madan K, Kulkarni A, Mohan
A, Dixit S, Guleria R, Bhattacharya P. Guidelines for Antibiotic Prescription in Intensive …